R. Edwards

发表

Phenylpropenamide Derivatives AT-61 and AT-130 Inhibit Replication of Wild-Type and Lamivudine-Resistant Strains of Hepatitis B Virus In Vitro

W. Delaney, S. Locarnini, G. Painter, 2002, Antimicrobial Agents and Chemotherapy.

Hepatitis B among immigrants from Myanmar: Genotypes and their clinical relevance

P. Revill, J. Sasadeusz, B. Biggs, 2018, Journal of medical virology.

Genotypic profiles of hepatitis B in African immigrants and their clinical relevance

P. Revill, J. Sasadeusz, B. Biggs, 2017, Journal of medical virology.

ALT flares during nucleotide analogue therapy are associated with HBsAg loss in genotype A HBeAg‐positive chronic hepatitis B

P. Marcellin, H. Janssen, K. Kitrinos, 2018, Liver international : official journal of the International Association for the Study of the Liver.

Molecular epidemiology of hepatitis delta virus in the Western Pacific region.

Q. Ning, S. Locarnini, S. Bowden, 2014, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

The phenylpropenamide derivative AT-130 blocks HBV replication at the level of viral RNA packaging.

S. Locarnini, J. Feld, D. Colledge, 2007, Antiviral research.

Drug-Resistant Strains of Hepatitis B Virus Recombinant Baculoviruses Which Encode Antihepadnaviral Compounds Using Novel Cross-Resistance Testing of

M. Manns, C. Trautwein, H. Isom, 2000 .

Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase.

Angeline Bartholomeusz, C. Gibbs, P. Angus, 2003, Gastroenterology.

Effect of the G1896A precore mutation on drug sensitivity and replication yield of lamivudine‐resistant HBV in vitro

H. Isom, W. Delaney, S. Locarnini, 2003, Hepatology.

242 Molecular modelling and functional studies of adefovir resistant mutations in the hepatitis B virus polymerase selected during therapy

P. Angus, H. Tillmann, B. Tehan, 2003 .

Deep sequencing shows that HBV basal core promoter and precore variants reduce the likelihood of HBsAg loss following tenofovir disoproxil fumarate therapy in HBeAg-positive chronic hepatitis B

M. Buti, P. Marcellin, R. Hammond, 2016, Gut.

Molecular virology of hepatitis B virus, sub‐genotype C4 in northern Australian Indigenous populations

B. Cowie, S. Tong, S. Locarnini, 2014, Journal of medical virology.

Molecular characterization of hepatitis B virus (HBV) in African children living in Australia identifies genotypes and variants associated with poor clinical outcome.

P. Revill, S. Locarnini, W. Hardikar, 2018, The Journal of general virology.

Hepatitis B and D in the Pacific Islands of Kiribati.

S. Locarnini, S. Nicholson, K. Jackson, 2020, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Tracing Ancient Human Migrations into Sahul Using Hepatitis B Virus Genomes.

S. Tong, S. Locarnini, S. Duchêne, 2019, Molecular biology and evolution.

Molecular epidemiology of hepatitis delta virus in the Western Pacific region.

Q. Ning, S. Locarnini, S. Bowden, 2014, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.